91B0FBB4-04A9-D5D7-16F0F3976AA697ED
9D9EFF11-C715-B4AD-C419B3380BA70DA7
  • Robert Hayden ’14 has been awarded a research/study Fulbright Grant to Copenhagen, Denmark. He will spend the 2014-15 academic year studying epidemiology and the development of medicines, and apply that coursework to biomedical research with the Copenhagen Hepatitis C (CO-HEP) Program group under the direction of Professor Jens Bukh. Hayden is a biochemistry and molecular biology major at Hamilton.

  • Associate Professor of Chemistry Myriam Cotten and her research team received instrument time at the National Institute of Standards and Technology (NIST). Samples were prepared at Hamilton by Kim Bogardus ’14, Jeremy Brendle ’14 and  Cotten and sent to collaborator Prof. Ella Mihailescu for analysis on MAGIK, a world-class instrument dedicated to me

  • Four Hamilton students presented their research at the 12th Molecular Educational Research Consortium in Undergraduate Computational chemistRY (MERCURY) conference held July 25-27 at Bucknell University.

    Topic
  • Kimberly Bogardus ’14 has been named a Barry M. Goldwater Scholar for the 2013-14 academic year. She is among 271 scholars from across the U.S. to receive the Goldwater, the premier national undergraduate award in the fields of mathematics, the natural sciences and engineering.

    Topic
  • Three Hamilton College faculty members were approved for tenure by the College’s Board of Trustees during a recent meeting. The Board granted tenure to Wei-Jen Chang (biology), Myriam Cotten (chemistry) and Heather Merrill (Africana studies).

    Topic
  • Associate Professor of Biology Mike McCormick presented the results of a multi-year research project conducted at Green Lakes State Park at the national meeting of American Society for Microbiology in New Orleans, May 21-25.

  • Rem Van Aiken Myers, a candidate for May graduation from Hamilton, has been awarded a Fulbright English Teaching Assistantship (ETA) to Indonesia.

  • For the entirety of her senior year, Gail Corneau ’10 will be pursuing research that targets MRSA staph infections, an antibiotic-resistant staphylococcus infection that can be fatal if untreated. Hospitals researching Vancomycin, a last resort antibiotic used to treat MRSA infections, recently discovered that Vancomycin-resistant bacteria strains have emerged during testing.

Help us provide an accessible education, offer innovative resources and programs, and foster intellectual exploration.

Site Search